Pulse Biosciences Inc.

16.53
0.59 (3.70%)
At close: Apr 02, 2025, 2:48 PM

Pulse Biosciences Statistics

Share Statistics

Pulse Biosciences has 61.52M shares outstanding. The number of shares has increased by 11.39% in one year.

Shares Outstanding 61.52M
Shares Change (YoY) 11.39%
Shares Change (QoQ) 0%
Owned by Institutions (%) 9.76%
Shares Floating 11.49M
Failed to Deliver (FTD) Shares 137
FTD / Avg. Volume 0.08%

Short Selling Information

The latest short interest is 2.13M, so 3.46% of the outstanding shares have been sold short.

Short Interest 2.13M
Short % of Shares Out 3.46%
Short % of Float 18.45%
Short Ratio (days to cover) 13.84

Valuation Ratios

The PE ratio is -18.97 and the forward PE ratio is -21.48. Pulse Biosciences's PEG ratio is -4.17.

PE Ratio -18.97
Forward PE -21.48
PS Ratio 0
Forward PS 28.5
PB Ratio 8.85
P/FCF Ratio -27.88
PEG Ratio -4.17
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Pulse Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.88, with a Debt / Equity ratio of 0.08.

Current Ratio 11.88
Quick Ratio 11.88
Debt / Equity 0.08
Debt / EBITDA -0.16
Debt / FCF -0.24
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-714.47K
Employee Count 75
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 107.54% in the last 52 weeks. The beta is 1.63, so Pulse Biosciences's price volatility has been higher than the market average.

Beta 1.63
52-Week Price Change 107.54%
50-Day Moving Average 18.68
200-Day Moving Average 17.38
Relative Strength Index (RSI) 38.69
Average Volume (20 Days) 172.89K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -56.26M
Net Income -53.59M
EBITDA -56.26M
EBIT n/a
Earnings Per Share (EPS) -0.92
Full Income Statement

Balance Sheet

The company has 118.04M in cash and 8.9M in debt, giving a net cash position of 109.14M.

Cash & Cash Equivalents 118.04M
Total Debt 8.9M
Net Cash 109.14M
Retained Earnings -390.5M
Total Assets 93.05M
Working Capital 73.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -36.34M and capital expenditures -125K, giving a free cash flow of -36.47M.

Operating Cash Flow -36.34M
Capital Expenditures -125K
Free Cash Flow -36.47M
FCF Per Share -0.62
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PLSE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for PLSE.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score 35.28
Piotroski F-Score 3